Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+8.5%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+8.5%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
1.3x
Solid growth
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 26.56% |
| Q3 2025 | -1.41% |
| Q2 2025 | -19.63% |
| Q1 2025 | 6.31% |
| Q4 2024 | 13.09% |
| Q3 2024 | -6.00% |
| Q2 2024 | -11.62% |
| Q1 2024 | -33.28% |
| Q4 2023 | 1.24% |
| Q3 2023 | -7.91% |
| Q2 2023 | -10.83% |
| Q1 2023 | -13.61% |
| Q4 2022 | 20.80% |
| Q3 2022 | -7.48% |
| Q2 2022 | -11.32% |
| Q1 2022 | 15.09% |
| Q4 2021 | -19.09% |
| Q3 2021 | 24.22% |
| Q2 2021 | -13.33% |
| Q1 2021 | 12.01% |
| Q4 2020 | -26.91% |
| Q3 2020 | 2.28% |
| Q2 2020 | 14.19% |
| Q1 2020 | -27.68% |
| Q4 2019 | 11.56% |
| Q3 2019 | -3.14% |
| Q2 2019 | -54.14% |
| Q1 2019 | 18.84% |
| Q4 2018 | -19.61% |
| Q3 2018 | -13.17% |
| Q2 2018 | -39.40% |
| Q1 2018 | -41.40% |
| Q4 2017 | 0.00% |